Cardiovascular Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Diagnostica Stago, Gennevilliers, France.
Int J Lab Hematol. 2018 Jun;40(3):251-257. doi: 10.1111/ijlh.12773. Epub 2018 Jan 22.
Factor VII activation occurs postprandially. A proportion of activated factor VII (VIIa) circulates in complex with antithrombin (VIIaAT). Our primary objective was to assess the effects of postprandial lipemia on circulating VIIaAT, procoagulant phospholipid (PPL) activity, and thrombin generation.
Plasma samples from postmyocardial infarction patients (n = 40) and controls (n = 39) were taken before and at 3 and 6 hours during a standardized oral fat tolerance test (OFTT). Fasting PPL activity measurements were also made in a second cohort of 108 postinfarction patients and 109 controls. VIIaAT was analyzed with the Asserachrom VIIaAT ELISA, PPL activity with the STA-Procoag-PPL kit, and thrombin generation with calibrated automated thrombogram with PRP-Reagent as trigger (all Diagnostica Stago products).
Postprandially, VIIaAT increased in all samples without significant case-control differences in the overall response during the OFTT. Thrombin generation measures peak height and velocity, and PPL activity, were marginally affected by the test meal in the controls. Levels of all patient baseline measures were significantly different from controls, indicating a more hypercoagulable state, and these differences were maintained throughout the OFTT. Fasting samples from cases showed higher PPL activity than control samples.
Viewing VIIaAT quantitation as a surrogate for TF activity measurement, postprandial increase in VIIaAT may reflect a mechanism that adds to the cardiovascular risk associated with postprandial lipemia. On the other hand, the impact of postprandial lipemia on PPL activity and thrombin generation seems to be minor.
因子 VII 在进食后被激活。一部分激活的因子 VII(VIIa)与抗凝血酶(VIIaAT)形成复合物循环。我们的主要目的是评估餐后脂血症对循环 VIIaAT、促凝血磷脂(PPL)活性和凝血酶生成的影响。
从心肌梗死患者(n=40)和对照组(n=39)中采集样本,在标准化口服脂肪耐量试验(OFTT)前和 3 小时和 6 小时时进行采集。还在另一组 108 名心肌梗死患者和 109 名对照组中进行了空腹 PPL 活性测量。使用 Asserachrom VIIaAT ELISA 分析 VIIaAT,使用 STA-Procoag-PPL 试剂盒分析 PPL 活性,使用带有 PRP-Reagent 作为触发剂的校准自动血栓图(所有 Diagnostica Stago 产品)分析凝血酶生成。
在整个 OFTT 过程中,所有样本均显示出 VIIaAT 的餐后增加,但病例组和对照组之间的总体反应没有显著差异。凝血酶生成测量峰值高度和速度,以及 PPL 活性,在对照组中受到试验餐的轻微影响。所有患者基线测量值的水平均与对照组明显不同,表明存在更易栓状态,并且这些差异在整个 OFTT 中保持不变。病例组的空腹样本显示出比对照组更高的 PPL 活性。
将 VIIaAT 定量视为 TF 活性测量的替代指标,VIIaAT 的餐后增加可能反映了一种增加与餐后脂血症相关的心血管风险的机制。另一方面,餐后脂血症对 PPL 活性和凝血酶生成的影响似乎较小。